Download PDF Flyer
Impact Factor Current: 2.719
5 - Year: 2.994

Current Vascular Pharmacology

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Latest Issue: Volume 20 , Issue 1 , 2022

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.719
5 - Year: 2.994

Ranking & Category

  • 42nd of 65 in Peripheral Vascular Disease
  • 164th of 261 in Pharmacology & Pharmacy

Topics Covered

1 Topics

Covered Diseases

1 Diseases


Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Abstracted/Indexed in

BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Current Contents® - Clinical Medicine, Current Contents® - Life Sciences, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier and Ulrich's Periodicals Directory

"Essential reading for cardiovascular scientists and physicians, pharmaceutical organizations and medical universities."

Greg Dusting
Univ. of Melbourne, Australia
Forthcoming Special Issue(s)

DIABETES AND OBESITY IN PREGNANCY: from patients to molecular mechanisms
Guest Editor(s): Luis Sobrevia
Submit Abstract via Email Download Description

Published Special Issue(s)

Novel therapeutic approaches towards the treatment of Vascular diseases

Guest Editor(s): Shams Tabrez

Download Description

Authors' Comments

I do want to compliment Bentham on the excellent processing of my manuscripts—the editorial and production works have been outstanding.

Thomas F. Whayne
(Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky Lexington, KY, United States.)

Has contributed: Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving.
© 2022 Bentham Science Publishers | Privacy Policy